Skip to content
Important: This site presents data from the FDA Adverse Event Reporting System (FAERS). A report does not mean the drug caused the event. Full disclaimer.

CABAZITAXEL for Bladder cancer: Side Effects & Safety Data

Boost Your Natural Energy & Metabolism

Mitolyn — 6 exotic plants to unlock your body's fat-burning power. 90-day guarantee.

Try Mitolyn Now

There are 23 adverse event reports in the FDA FAERS database where CABAZITAXEL was used for Bladder cancer.

Most Reported Side Effects for CABAZITAXEL

Side Effect Reports % Deaths Hosp.
Febrile neutropenia 197 7.7% 66 119
Malignant neoplasm progression 172 6.7% 18 23
Fatigue 160 6.3% 17 67
Prostatic specific antigen increased 148 5.8% 11 23
Pyrexia 145 5.7% 48 94
Disease progression 143 5.6% 46 27
Diarrhoea 142 5.6% 34 70
Anaemia 127 5.0% 30 58
Neutropenia 126 4.9% 27 50
Drug ineffective 125 4.9% 25 20
Dyspnoea 113 4.4% 42 49
Haematuria 108 4.2% 11 49
Asthenia 101 4.0% 18 59
Decreased appetite 89 3.5% 18 52
Nausea 81 3.2% 13 41

Other Indications for CABAZITAXEL

Prostate cancer (764) Hormone-refractory prostate cancer (524) Prostate cancer metastatic (451) Product used for unknown indication (237) Metastases to bone (28) Adenocarcinoma (27) Neoplasm malignant (20) Chemotherapy (17) Prostate cancer stage iv (15) Bone cancer (11)

Other Drugs Used for Bladder cancer

BACILLUS CALMETTE-GUERIN SUBSTRAIN TICE LIVE ANTIGEN (1,279) PEMBROLIZUMAB (869) GEMCITABINE (841) CISPLATIN (780) ENFORTUMAB VEDOTIN-EJFV (530) NIVOLUMAB (512) ATEZOLIZUMAB (487) CARBOPLATIN (332) BACILLUS CALMETTE-GUERIN ANTIGEN, UNSPECIFIED SUBSTRAIN (326) GEMCITABINE\GEMCITABINE (240)

Related Pages

CABAZITAXEL Full Profile All Bladder cancer Drugs CABAZITAXEL Demographics CABAZITAXEL Timeline